BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis

  Pharus Diagnostics announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma.

  February 15, 2024

   · 

  4 min read
• Policy

  Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®

  Diamyd Medical announced that the U.S. Food and Drug Administration has granted Fast Track designation for Diamyd® that is being investigated to improve glycemic control in recently diagnosed stage 3 Type 1 Diabetes patients with the genotype HLA DR3-DQ2.

  February 15, 2024

   · 

  4 min read
• Business

  Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

  Amicus Therapeutics announced that the Company will host a conference call and live audio webcast on Wednesday, February 28, 2024, at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2023.

  February 15, 2024

   · 

  1 min read
• Business

  Acarix Strengthens U.S. Team with Three Key Advisors

  Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team.

  February 15, 2024

   · 

  3 min read
• Business

  Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

  Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024.

  February 15, 2024

   · 

  5 min read
• Business

  Labcorp Announces 2023 Fourth Quarter and Full Year Results

  Labcorp, a global leader of innovative and comprehensive laboratory services, announced results for the fourth quarter and year ending Dec. 31, 2023, and full year 2024 guidance.

  February 15, 2024

   · 

  24 min read
• Business

  Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024

  Alkermes plc reported financial results for the quarter and year ended Dec. 31, 2023 and provided financial expectations for 2024.

  February 15, 2024

   · 

  23 min read
• BioMidwest

  SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices

  SkyWater Technology, the trusted technology realization partner, announced it has signed a production agreement with Nautilus Biotechnology, Inc. to supply silicon-based microfluidic bio chips for Nautilus’ proteome analysis system.

  February 15, 2024

   · 

  4 min read
• Business

  Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update

  Arbutus Biopharma Corporation announced that it has scheduled its fourth quarter and year end 2023 financial results and corporate update for Thursday, February 29, 2024.

  February 15, 2024

   · 

  1 min read
• Business

  Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis

  Intellia Therapeutics, Inc. and ReCode Therapeutics announced a strategic collaboration to develop novel genomic medicines for the treatment of cystic fibrosis.

  February 15, 2024

   · 

  7 min read